Juan José Otero Forero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juan José Otero Forero has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Porras
Unidad de Gestión Clínica del Corazón y Patología Cardiovascular, Servicio de Cirugía Cardíaca, Hospital Universitario Virgen de la Victoria, Málaga, España
3 shared publications - Emiliano Andrés Rodríguez Caulo
Cardiovascular Surgery Department, Virgen de la Macarena University Hospital, Sevilla, Spain
3 shared publications - Gemma Sánchez-Espín
Unidad de Gestión Clínica del Corazón, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA), CIBERCV Enfermedades Cardiovasculares, Málaga, Spain
3 shared publications - Ana Guijarro-Contreras
Unidad de Gestión Clínica del Corazón, Hospital Clínico Universitario Virgen de la Victoria de Málaga; Instituto Biotecnológico de Málaga, Centro de Investigación Biomédica en Enfermedades Cardiovasculares, Málaga, Spain (A.G.-C.).
1 shared publication - Antonio Ordóñez
Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).
1 shared publication - Aranta Guzón-Rementería
Unidad de Gestión Clínica del Corazón, Hospital Virgen de la Victoria de Málaga, Málaga, Spain, Instituto Biosanitario Málaga (IBIMA), CIBERCV Málaga. Universidad de Málaga (UMA), Málaga, Spain.
1 shared publication
Latest Publications
- Open Access
- 17 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Quality of life, satisfaction and outcomes after ministernotomy versus full sternotomy isolated aortic valve replacement (QUALITY-AVR): study protocol for a randomised controlled trial
During the last decade, the use of ministernotomy in cardiac surgery has increased. Quality of life and patient satisfaction after ministernotomy have never been compared to conventional full sternotomy in randomised trials. The aim of the study is to determine if this minimally invasive approach improves quality of life, satisfaction and clinical morbimortality outcomes. The QUALITY-AVR trial is a single-blind, single-centre, independent, and pragmatic randomised clinical trial comparing ministernotomy (“J” shaped upper hemisternotomy toward right 4th intercostal space) to full sternotomy in patients with isolated severe aortic stenosis scheduled for elective aortic valve replacement. One hundred patients will be randomised in a 1:1 computational fashion. Sample size was determined for the primary end point with alpha error of 0.05 and with power of 90% in detecting differences between intervention groups of ≥ 0.10 points in change from baseline quality of life Questionnaire EuroQOL-index (EQ-5D-5 L®), measured at 1, 6 or 12 months. Secondary endpoints are: the differences in change from other baseline EQ-5D-5 L® utilities (visual analogue scale, Health Index and Severity Index), cardiac surgery specific satisfaction questionnaire (SATISCORE®), a combined safety endpoint of four major adverse complications at 1 month (all-cause mortality, acute myocardial infarction, neurologic events and acute renal failure), bleeding through drains within the first 24 h, intubation time, postoperative hospital and intensive care unit length of stay, transfusion needs during the first 72 h and 1-year survival rates. Clinical follow up is scheduled at baseline, 1, 6, and 12 months after randomization. All clinical outcomes are recorded following the Valve Academic Research Consortium 2 criteria. The QUALITY-AVR trial aims to test the hypothesis that ministernotomy improves quality of life, satisfaction and clinical outcomes in patients referred for isolated aortic valve replacement. Statistically significant differences favouring ministernotomy could modify the surgical “gold standard” for aortic stenosis surgery, and subsequently the need to change the control group in transcatheter aortic valve implantation trials. Recruitment started on 18 March 2016. In November 2017, 75 patients were enrolled. ClinicalTrials.gov, NCT02726087. Registered on 13 March 2016.
- 17 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Open AccessQuality of life, satisfaction and outcomes after ministernotomy versus full sternotomy isolated aortic valve replacement (QUALITY-AVR): study protocol for a randomised controlled trial
During the last decade, the use of ministernotomy in cardiac surgery has increased. Quality of life and patient satisfaction after ministernotomy have never been compared to conventional full sternotomy in randomised trials. The aim of the study is to determine if this minimally invasive approach improves quality of life, satisfaction and clinical morbimortality outcomes. The QUALITY-AVR trial is a single-blind, single-centre, independent, and pragmatic randomised clinical trial comparing ministernotomy (“J” shaped upper hemisternotomy toward right 4th intercostal space) to full sternotomy in patients with isolated severe aortic stenosis scheduled for elective aortic valve replacement. One hundred patients will be randomised in a 1:1 computational fashion. Sample size was determined for the primary end point with alpha error of 0.05 and with power of 90% in detecting differences between intervention groups of ≥ 0.10 points in change from baseline quality of life Questionnaire EuroQOL-index (EQ-5D-5 L®), measured at 1, 6 or 12 months. Secondary endpoints are: the differences in change from other baseline EQ-5D-5 L® utilities (visual analogue scale, Health Index and Severity Index), cardiac surgery specific satisfaction questionnaire (SATISCORE®), a combined safety endpoint of four major adverse complications at 1 month (all-cause mortality, acute myocardial infarction, neurologic events and acute renal failure), bleeding through drains within the first 24 h, intubation time, postoperative hospital and intensive care unit length of stay, transfusion needs during the first 72 h and 1-year survival rates. Clinical follow up is scheduled at baseline, 1, 6, and 12 months after randomization. All clinical outcomes are recorded following the Valve Academic Research Consortium 2 criteria. The QUALITY-AVR trial aims to test the hypothesis that ministernotomy improves quality of life, satisfaction and clinical outcomes in patients referred for isolated aortic valve replacement. Statistically significant differences favouring ministernotomy could modify the surgical “gold standard” for aortic stenosis surgery, and subsequently the need to change the control group in transcatheter aortic valve implantation trials. Recruitment started on 18 March 2016. In November 2017, 75 patients were enrolled. ClinicalTrials.gov, NCT02726087. Registered on 13 March 2016.
- Open Access
- 1 January 2018
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 25 (1) , 48-50
Rara complicación con un catéter de Swan-Ganz
- 1 January 2018
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 25 (1) , 48-50
Open AccessRara complicación con un catéter de Swan-Ganz
- Open Access
- 1 November 2015
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 22 (6) , 294-296
Experiencia inicial en implantación de electrodos endocavitarios en pacientes portadores de bioprótesis tricúspides
- 1 November 2015
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 22 (6) , 294-296
Open AccessExperiencia inicial en implantación de electrodos endocavitarios en pacientes portadores de bioprótesis tricúspides